AI English summary of an SEC filing — figures as filed
Cardinal Health CAHCardinal Health said second quarter fiscal 2025 revenue decreased 4% to $55.3 billion; excluding the impact of the previously communicated large customer contract expiration, revenue increased 16%.
Key points
AI summaryCardinal Health said second quarter fiscal 2025 revenue decreased 4% to $55.3 billion; excluding the impact of the previously communicated large customer contract expiration, revenue increased 16%.
The company said second quarter GAAP operating earnings were $549 million and GAAP diluted EPS were $1.65. Non-GAAP operating earnings increased 9% to $635 million, and non-GAAP diluted EPS increased 2% to $1.93.
Cardinal Health raised its fiscal 2025 non-GAAP diluted EPS guidance to $7.85 to $8.00, from $7.75 to $7.90. The company said the guidance now reflects the impacts of the completed acquisitions of Integrated Oncology Network and its majority stake in GI Alliance.
The company announced the completion of its acquisition of a 73% stake in GI Alliance. It also completed its acquisition of Integrated Oncology Network in December, with acquisition consideration paid, net of cash acquired, of $1,076 million in Q2.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q2 Revenue $55.3 billion, Impact of Large Customer Contract Expiration
Cardinal Health said second quarter fiscal 2025 revenue decreased 4% to $55.3 billion; excluding the impact of the previously communicated large customer contract expiration, revenue increased 16%.
Source · Based on the filing body and exhibits
Q2 GAAP and Non-GAAP Operating Earnings and Diluted Earnings Per Share
The company said second quarter GAAP operating earnings were $549 million and GAAP diluted EPS were $1.65. Non-GAAP operating earnings increased 9% to $635 million, and non-GAAP diluted EPS increased 2% to $1.93.
Source · Based on the filing body and exhibits
Fiscal 2025 Non-GAAP EPS Guidance Raised
Cardinal Health raised its fiscal 2025 non-GAAP diluted EPS guidance to $7.85 to $8.00, from $7.75 to $7.90. The company said the guidance now reflects the impacts of the completed acquisitions of Integrated Oncology Network and its majority stake in GI Alliance.
Source · Based on the filing body and exhibits
GI Alliance Acquisition Completed and Integrated Oncology Network Acquisition
The company announced the completion of its acquisition of a 73% stake in GI Alliance. It also completed its acquisition of Integrated Oncology Network in December, with acquisition consideration paid, net of cash acquired, of $1,076 million in Q2.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…